Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,6139756,half-life,"After the i.v. administration of either salt, phenobarbital plasma levels declined monoexponentially with a half-life of 7.5 h; the volume of distribution was 0.78 l/kg.",Pharmacokinetics of phenobarbital and propylhexedrine after administration of barbexaclone in the mouse. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/6139756/),h,7.5,176321,DB06714,Propylhexedrine
,6139756,volume of distribution,"After the i.v. administration of either salt, phenobarbital plasma levels declined monoexponentially with a half-life of 7.5 h; the volume of distribution was 0.78 l/kg.",Pharmacokinetics of phenobarbital and propylhexedrine after administration of barbexaclone in the mouse. ,V-Q61,[Article Link](https://pubmed.ncbi.nlm.nih.gov/6139756/),[l] / [kg],0.78,176322,DB06714,Propylhexedrine
,6139756,t0.5 alpha,"After i.v. application of barbexaclone the following pharmacokinetic parameters for propylhexedrine were determined: t0.5 alpha 0.31 h, t0.5 beta 2.5 h, Vd beta 19.3 l/kg; bioavailability (AUC oral/AUC i.v.) 0.37.",Pharmacokinetics of phenobarbital and propylhexedrine after administration of barbexaclone in the mouse. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/6139756/),h,0.31,176323,DB06714,Propylhexedrine
,6139756,t0.5 beta,"After i.v. application of barbexaclone the following pharmacokinetic parameters for propylhexedrine were determined: t0.5 alpha 0.31 h, t0.5 beta 2.5 h, Vd beta 19.3 l/kg; bioavailability (AUC oral/AUC i.v.) 0.37.",Pharmacokinetics of phenobarbital and propylhexedrine after administration of barbexaclone in the mouse. ,"t1/2,Î²-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/6139756/),h,2.5,176324,DB06714,Propylhexedrine
,6139756,Vd beta,"After i.v. application of barbexaclone the following pharmacokinetic parameters for propylhexedrine were determined: t0.5 alpha 0.31 h, t0.5 beta 2.5 h, Vd beta 19.3 l/kg; bioavailability (AUC oral/AUC i.v.) 0.37.",Pharmacokinetics of phenobarbital and propylhexedrine after administration of barbexaclone in the mouse. ,V-Q61,[Article Link](https://pubmed.ncbi.nlm.nih.gov/6139756/),[l] / [kg],19.3,176325,DB06714,Propylhexedrine
,6139756,bioavailability (AUC oral/AUC,"After i.v. application of barbexaclone the following pharmacokinetic parameters for propylhexedrine were determined: t0.5 alpha 0.31 h, t0.5 beta 2.5 h, Vd beta 19.3 l/kg; bioavailability (AUC oral/AUC i.v.) 0.37.",Pharmacokinetics of phenobarbital and propylhexedrine after administration of barbexaclone in the mouse. ,F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/6139756/),,0.37,176326,DB06714,Propylhexedrine
